bioRxiv · 10.1101/2023.07.21.550074
isGWAS: ultra-high-throughput, scalable and equitable inference of genetic associations with disease
Abstract
Genome-wide association studies (GWAS) have proven a powerful tool for human geneticists to generate biological insights or hypotheses for drug discovery. Nevertheless, a dependency on sensitive individual-level data together with ever-increasing cohort sample sizes, numbers of variants and phenotypes studied put a strain on existing algorithms, limiting the GWAS approach from maximising potential. Here we present in-silico GWAS (isGWAS), a uniquely scalable algorithm to infer regression parameters in case-control GWAS from cohort-level summary data. For any sample size, isGWAS computes a variant-disease association parameter in [~]1 millisecond, or [~]11m variants in UK-Biobank within [~]4 minutes ([~]1500-fold faster than state-of-the-art). Extensive simulations and empirical tests demonstrate that isGWAS results are highly comparable to traditional regression-based approaches. We further introduce a heuristic re-sampling algorithm, leapfrog re-sampler (LRS), to extrapolate association results to semi-virtually enlarged cohorts. Owing to significant computational gains we anticipate a broad use of isGWAS and LRS which are customizable on a web interface.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Foley, C. N., Kuncheva, Z., Marioni, R., Runz, H., Sun, B.. 2023-07-25. isGWAS: ultra-high-throughput, scalable and equitable inference of genetic associations with disease. https://doi.org/10.1101/2023.07.21.550074
Cite the original work for its findings. Save a collection to share your selection of sources.